The costs associated with sleep symptoms among patients with fibromyalgia

Expert Review of Pharmacoeconomics and Outcomes Research

Volumn 13, Issue 1, 2013, Pages 131-139

  Wagner, Jan Samuel ^a   Chandran, Arthi ^b   Dibonaventura, Marco ^a   Cappelleri, Joseph C ^b  

^a KANTAR HEALTH   (United States)

^b PFIZER INC   (United States)

Author keywords

direct costs; fibromyalgia; indirect costs; sleep symptoms

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; CHARLSON COMORBIDITY INDEX; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST CONTROL; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; EMERGENCY CARE; FEMALE; FIBROMYALGIA; HEALTH CARE COST; HELP SEEKING BEHAVIOR; HOSPITALIZATION COST; HUMAN; INSOMNIA; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL FEE; MEDICAL HISTORY; QUALITY OF LIFE; SLEEP DISORDER; UNITED STATES; WORK DISABILITY;

ABSENTEEISM; ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COST OF ILLNESS; COST SAVINGS; EMERGENCY SERVICE, HOSPITAL; FEMALE; FIBROMYALGIA; HEALTH CARE COSTS; HEALTH CARE SURVEYS; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; OFFICE VISITS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP; SLEEP DISORDERS; UNITED STATES;

EID: 84873924343     PISSN: 14737167     EISSN: 17448379     Source Type: Journal    
DOI: 10.1586/erp.12.82     Document Type: Article

References (29)

1. Wolfe F, Clauw DJ, Fitzcharles MA et al. The American College of Rheumatology preliminary diagnostic criteria for fbromy algia and measurement of symptom severity. Arthritis Care Res. 62, 600-610 (2010).
2. Lawrence RC, Felson DT, Helmick CG et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58(1), 26-35 (2008).
3. Geenen R, Jacobs JW Fibromyalgia: diagnosis, pathogenesis, and treatment. Curr. Opin. Anaesthesiol. 14(5), 533-539 (2001).
4. Hoffman DL, Dukes EM. The health status burden of people with fbromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12. Int. J. Clin. Pract. 62(1), 115-126 (2008).
5. McDonald M, DiBonaventura MD, Ullman S. Musculoskeletal pain in the workforce: the effects of back, arthritis, and fbromyalgia pain on quality of life and work productivity. J. Occup. Environ. Med. 53(7), 765-770 (2011).
6. Söderberg S, Strand M, Haapala M, Lundman B. Living with a woman with fbromyalgia from the perspective of the husband. J. Adv. Nurs. 42(2), 143-150 (2003).
7. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fbromyalgia syndrome. Int. J. Clin. Pract. 61(9), 1498-1508 (2007).
8. Palacio A, Uribe CL, Li H et al. Financial and clinical characteristics of fbromyalgia: a case-control comparison. Am. J. Manag. Care 16(Suppl. 5), S118-S125 (2010).
9. Wolfe F, Anderson J, Harkness D et al Health status and disease severity in fbromyalgia: results of a six-center longitudinal study. Arthritis Rheum. 40(9), 1571-1579 (1997).
10. Arnold LM, Crofford LJ, Mease PJ et al Patient perspectives on the impact of fbromyalgia. Patient Educ. Couns. 73(1), 114-120 (2008).
11. White LA, Birnbaum HG, Kaltenboeck A, Tang J, Mallett D, Robinson RL. Employees with fbromyalgia: medical comorbidity, healthcare costs, and work loss. J. Occup. Environ. Med. 50(1), 13-24 (2008).
12. Kivimäki M, Leino-Arjas P, Kaila-Kangas L et al. Increased absence due to sickness among employees with fbromyalgia. Ann. Rheum. Dis. 66(1), 65-69 (2007).
13. Kleinman N, Harnett J, Melkonian A, Lynch W, Kaplan-Machlis B, Silverman SL. Burden of fbromyalgia and comparisons with osteoarthritis in the workforce. J. Occup. Environ. Med. 51(12), 1384-1393 (2009).
14. Winkelmann A, Perrot S, Schaefer C et al. Impact of fbromyalgia severity on health economic costs: results from a European cross-sectional study. Appl. Health Econ. Health Policy 9(2), 125-136 (2011).
15. Wolfe F, Pincus T Standard self-report questionnaires in routine clinical and research practice-an opportunity for patients and rheumatologists. J. Rheumatol 18(5), 643-646 (1991).
16. Theadom A, Cropley M, Humphrey KL. Exploring the role of sleep and coping in quality of life in fbromyalgia. J. Psychosom. Res. 62(2), 145-151 (2007).
17. Bigatti SM, Hernandez AM, Cronan TA, Rand KL. Sleep disturbances in fbromyalgia syndrome: relationship to pain and depression. Arthritis Rheum. 59(7), 961-967 (2008).
18. Davies KA, Macfarlane GJ, Nicholl BI et al. Restorative sleep predicts the resolution of chronic widespread pain: results from the EPIFUND study. Rheumatology (Oxford) 47(12), 1809-1813 (2008).
19. Finkelstein EA, Allaire BT, DiBonaventura MD, Burgess SM. Direct and indirect costs and potential cost savings of laparoscopic adjustable gastric banding among obese patients with diabetes. J. Occup. Environ. Med. 53(9), 1025-1029 (2011).
20. DiBonaventura MD, Wagner JS, Yuan Y, L'Italien G, Langley P, Ray Kim W. Humanistic and economic impacts of hepatitis C infection in the United States. J. Med. Econ. 13(4), 709-718 (2010).
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40(5), 373-383 (1987).
22. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a Work Productivity and Activity Impairment Instrument. Pharmacoeconomics 4(5), 353-365 (1993).
23. Reilly MC, Gooch KL, Wong RL, Kupper H, van der Heijde D. Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis. Rheumatology (Oxford) 49(4), 812-819 (2010).
24. Zhang W, Bansback N, Boonen A, Young A, Singh A, Anis AH. Validity of the Work Productivity and Activity Impairment Questionnaire-general health version in patients with rheumatoid arthritis. Arthritis Res. Ther. 12(5), R177 (2010).
25. Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey (2008).
26. US Bureau of Labor Statistics. Highlight of Women's Earnings in 2009 (Report 1025). US Department of Labor, Washington, DC, USA (2010).
27. Lofand JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments. Pharmacoeconomics 22(3), 165-184 (2004).
28. DiBonaventura MD, Gupta S, McDonald M, Sadosky A, Pettitt D, Silverman S. Impact of self-rated osteoarthritis severity in an employed population: cross-sectional analysis of data from the National Health and Wellness Survey. Health Qual. Life Outcomes 10, 30 (2012).
29. Annemans L, Le Lay K, Taïeb C. Societal and patient burden of fbromyalgia syndrome. Pharmacoeconomics 27(7), 547-559 (2009).